Nanobiotix FY 2023 GAAP EPS $(1.17) Beats $(1.66) Estimate, Sales $39.323M Beat $13.680M Estimate
Nanobiotix FY 2023 GAAP EPS $(1.17) Beats $(1.66) Estimate, Sales $39.323M Beat $13.680M Estimate
Nanobiotix2023財年GAAP每股收益美元（1.17美元）超過預期（1.66美元），銷售額39323萬美元超過預期的136.8億美元
Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(1.17) per share which beat the analyst consensus estimate of $(1.66) by 29.52 percent. This is a 32.37 percent increase over losses of $(1.73) per share from the same period last year. The company reported quarterly sales of $39.323 million which beat the analyst consensus estimate of $13.680 million by 187.45 percent. This is a 681.30 percent increase over sales of $5.033 million the same period last year.
Nanobiotix（納斯達克股票代碼：NBTX）公佈的季度虧損爲每股1.17美元，比分析師普遍預期的1.66美元（1.66美元）高出29.52％。這比去年同期每股虧損1.73美元（1.73美元）增長了32.37％。該公司公佈的季度銷售額爲3932.3萬美元，比分析師普遍預期的136.8億美元高出187.45％。這比去年同期的503.3萬美元的銷售額增長了681.30％。